U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07383363) titled 'Comparison of Efficacy and Safety of Vita 6 Versus Zinc Along With Applied Behavioural Therapy' on Jan. 26.
Brief Summary: The study seeks to fill the gaps in available local data regarding the diagnosis and its management, as multiple treatments are in practice. Therefore, the study aimed at the comparison of efficacy and safety of Vita 6 versus zinc along with applied behavioral therapy in the management of autism spectrum disorder in children aged 3-14 years.
Study Start Date: Sept. 23, 2025
Study Type: INTERVENTIONAL
Condition:
Autism Spectrum Disorder
Intervention:
DRUG: Vita 6
Patients will be given one tablet of Vita 6 ...